SINGAPORE (Dec 5): iX Biopharma has been awarded a cannabis manufacture license from the Australian Office of Drug Control to manufacture and supply extracts and tinctures of cannabis and cannabis resins.

The specialty pharmaceutical company’s wholly-owned subsidiary, iX Syrinx, operates a TGA cGMP certified facility, and holds import and export licences for cannabis and state poisons licences.

Together with the newly granted cannabis manufacture licence, the group is now able to fully participate in the global medicinal cannabis business.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook